Company type | Public |
---|---|
| |
Industry | Healthcare |
Founded |
|
Headquarters | Heller International Building, Chicago, Illinois , United States |
Area served | Worldwide |
Key people |
|
Revenue | US$19.6 billion (2023) |
US$2.4 billion (2023) | |
US$1.6 billion (2023) | |
Total assets | US$32.5 billion (2023) |
Total equity | US$7.2 billion (2023) |
Number of employees | c. 51,000 (2023) |
Parent | General Electric |
Website | gehealthcare |
Footnotes / references [1] |
GE HealthCare Technologies, Inc.[1] is an American multinational health technology company headquartered in Chicago, Illinois.[2]
The company operates 4 divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures contrast agents and radiopharmaceuticals.[1]
The company's primary customers are hospitals and health networks.[3] In 2023, the company received 42% of its revenue in the United States and 13% of its revenue from China, where the company faces increasing competition.[3]
The company operates in more than 100 countries. GE HealthCare has major regional operations in Buc (suburb of Paris), France; Helsinki, Finland; Kraków, Poland; Budapest, Hungary; Yizhuang (suburb of Beijing), China; Hino & Tokyo, Japan, and Bangalore, India. Its biggest R&D center is in Bangalore, India, built at a cost of $50 million.[4]
General Electric completed the corporate spin-off of the company in January 2023.